Dreman Value Management’s Biogen BIIB Stock Holding History

Dreman Value Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.01M	Hold	3,705	–	–	0.46%	52
2017 Q4	$1.18M	Hold	3,705	–	–	0.67%	41
2017 Q3	$1.16M	Hold	3,705	–	–	0.64%	41
2017 Q2	$1M	Buy	+3,705	New	+$980K	0.55%	54
2017 Q1	–	Sell	-602	Closed	-$171K	–	259
2016 Q4	$171K	Buy	602 +452	+301%	+$134K	0.1%	247
2016 Q3	$47K	Hold	150	–	–	0.03%	234
2016 Q2	$36K	Buy	+150	New	+$39.5K	0.02%	260

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dreman Value Management's BIIB Position: Q1 2018 in Review

Dreman Value Management held its Biogen (BIIB) position steady in Q1 2018 at 3,705 shares worth $1.01M. The position accounts for 0.46% of the portfolio, ranked #52.

Dreman Value Management first reported a position in BIIB in Q2 2016 and has held it in 7 quarters since. The position peaked at $1.18M in Q4 2017. 1,101 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

Dreman Value Management held 3,705 shares of Biogen worth $1.01M as of Q1 2018.
Dreman Value Management left its Biogen share count unchanged in Q1 2018.
Biogen made up 0.46% of Dreman Value Management's portfolio in Q1 2018, its #52 holding.
Dreman Value Management first reported a position in Biogen in Q2 2016 and has held it in 7 quarters since.
Dreman Value Management's Biogen position peaked at $1.18M in Q4 2017.
1,101 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.